Svas Biosana S.p.A. (BIT:SVS)

Market Cap	38.60M
Revenue (ttm)	123.79M
Net Income (ttm)	5.45M
Shares Out	5.40M
EPS (ttm)	n/a
PE Ratio	7.08
Forward PE	6.68
Dividend	0.30 (4.26%)
Ex-Dividend Date	n/a

Volume	4,357
Average Volume	1,898
Open	7.10
Previous Close	6.95
Day's Range	7.00 - 7.35
52-Week Range	6.50 - 8.55
Beta	0.87
RSI	38.37
Earnings Date	Apr 14, 2025

About Svas Biosana

SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels that are used in haemodynamic, heart surgery, anaesthesia, and critical care applications. In addition, the company provides specialist medical devices for use in onc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 323
• Stock Exchange: Borsa Italiana
• Ticker Symbol: SVS

Financial Performance

In 2023, Svas Biosana's revenue was 121.63 million, an increase of 22.22% compared to the previous year's 99.51 million. Earnings were 5.12 million, an increase of 43.52%.